Gropalis Maria, Bleichhardt Gaby, Witthöft Michael, Hiller Wolfgang
Department of Psychology, University of Mainz, Mainz, Germany.
J Nerv Ment Dis. 2012 May;200(5):406-12. doi: 10.1097/NMD.0b013e31825322e5.
The question of whether hypochondriasis (HYP) should be considered a somatoform disorder (SFD) or classified as an anxiety disorder (ANX) has recently been raised. To empirically provide information on this issue, we compared patients with HYP (n = 65) with those with other SFDs (n = 94) and those with ANX (n = 224) regarding sociodemographic and biographical variables, general psychopathology, and naturalistic cognitive-behavioral therapy treatment effects. Compared with SFD, patients with HYP were younger and had fewer comorbid affective disorders and less impaired life domains, suggesting a closer connection between HYP and ANX. Regarding cognitive-behavioral therapy treatment effects, all diagnostic groups showed comparable significant improvement (d = 0.44-0.64). According to level of anxiety, the SFD sample had significantly lower pretreatment scores than did the ANX and the HYP samples. The results suggest that patients with HYP have an interim position between SFD and ANX, with slightly closer connections to ANX.
近来有人提出，疑病症（HYP）究竟应被视为一种躯体形式障碍（SFD）还是归类为焦虑症（ANX）的问题。为了从实证角度提供有关此问题的信息，我们比较了疑病症患者（n = 65）与其他躯体形式障碍患者（n = 94）以及焦虑症患者（n = 224）在社会人口统计学和个人经历变量、一般精神病理学以及自然主义认知行为疗法治疗效果方面的情况。与躯体形式障碍患者相比，疑病症患者更年轻，共病情感障碍更少，生活领域受损程度更低，这表明疑病症与焦虑症之间的联系更为紧密。关于认知行为疗法的治疗效果，所有诊断组均显示出相当显著的改善（d = 0.44 - 0.64）。根据焦虑水平，躯体形式障碍样本的治疗前得分显著低于焦虑症样本和疑病症样本。结果表明，疑病症患者处于躯体形式障碍和焦虑症之间的中间位置，与焦虑症的联系稍紧密一些。
